User Tools

Site Tools


endocrine:start

This is an old revision of the document!


Endocrine Pharmacology

Endocrine pharmacology is organized by hormonal organ systems.

Each section links to physiology, pathophysiology, drug classes, and therapeutic strategy.


Diabetes & Glucose Regulation

1. Hypoglycemics (Increase Insulin Effect)

These agents increase insulin levels and carry hypoglycemia risk. Insulin Therapy

Rapid-Acting (Prandial)

Short-Acting

Intermediate-Acting

  • NPH (Humulin N®, Novolin N®)

Long-Acting (Basal)

Ultra-Long Acting

Sulfonylureas

Meglitinides

2. Anti-Hyperglycemics (Low Hypoglycemia Risk)

These agents improve glycemia without directly increasing insulin secretion.

Biguanides

Thiazolidinediones (TZDs)

GLP-1 Receptor Agonists

Dual GLP-1/GIP Incretin Agonists

Triple Incretin Agonists

SGLT2 Inhibitors

Thyroid

Thyroid Hormone Replacement

Antithyroid Drugs

Iodine Therapy

Symptom Control in Hyperthyroidism

Adrenal

Glucocorticoids

  • Prednisone (Deltasone®)
  • Hydrocortisone (Cortef®)
  • Dexamethasone (Decadron®)

Mineralocorticoids

  • Fludrocortisone (Florinef®)

Steroid Synthesis Inhibitors

  • Ketoconazole
  • Metyrapone

Pituitary

Dopamine Agonists

  • Cabergoline (Dostinex®)
  • Bromocriptine (Parlodel®)

Somatostatin Analogs

  • Octreotide (Sandostatin®)
  • Lanreotide (Somatuline®)

Growth Hormone Therapies

Vasopressin & Analogues

  • Desmopressin (DDAVP®)

Reproductive Endocrinology

Estrogen Therapy

Progesterone Therapy

Hormonal Contraception

Selective Estrogen Receptor Modulators (SERMs)

  • Tamoxifen (Nolvadex®)
  • Raloxifene (Evista®)

Antiandrogens

  • Spironolactone (Aldactone®)
  • Finasteride (Proscar®, Propecia®)

Bone & Mineral Metabolism

Anti-Resorptive Agents

[[endocrine:bone:bisphosphonates|Bisphosphonates]]

Oral:

IV:

Used in:

  • Osteoporosis
  • Paget disease
  • Hypercalcemia of malignancy
  • Bone metastases

[[endocrine:bone:rankl_inhibitors|RANKL Inhibitors]]


[[endocrine:serm:start|Selective Estrogen Receptor Modulators (SERMs)]]


[[endocrine:calcitonin|Calcitonin]]

Rarely used today.


Anabolic / Bone-Forming Agents

[[endocrine:bone:pth_analogs|Parathyroid Hormone Analogs]]


[[endocrine:bone:sclerostin_inhibitors|Sclerostin Inhibitors]]


Vitamin D & Calcium Axis

[[endocrine:bone:vitamin_d|Vitamin D & Analogs]]

Nutritional:

Active Forms:


Calcium Supplements

Hyperparathyroidism / CKD-MBD

[[endocrine:bone:calcimimetics|Calcimimetics]]


Phosphate Binders

Calcium-based:

Non-calcium:


FGF23 Pathway

Used in:

  • X-linked hypophosphatemia

Clinical Groupings

Osteoporosis:

  • Bisphosphonates
  • Denosumab
  • Teriparatide / Abaloparatide
  • Romosozumab
  • Raloxifene

CKD–Mineral Bone Disease:

  • Vitamin D analogs
  • Calcimimetics
  • Phosphate binders

Hypercalcemia:

  • IV Bisphosphonates
  • Denosumab
  • Calcitonin

Paget Disease:

  • Bisphosphonates


Related:

endocrine/start.1770991618.txt.gz · Last modified: by andrew2393cns